Table 2.
Indication for LT | n (%) |
---|---|
Hepatocellular carcinoma | 10 (23) |
Primary sclerosing cholangitis | 7 (16) |
Alcohol-induced liver cirrhosis | 6 (14) |
Hepatitis C virus-induced liver cirrhosis | 3 (7) |
Acute liver failure | 3 (7) |
Wilson’s disease | 3 (7) |
Cryptogenic liver cirrhosis | 2 (4.7) |
α-1 antitrypsin deficiency | 2 (4.7) |
Others 1 | 7 (16) |
1 Others: autoimmunhepatitis, polycystic liver and kidney disease, hepatitis B virus-induced liver cirrhosis, Alagille syndrome, and neuroendocrine tumor (n = 1 each).